Skip to main content
Fig. 5 | Cancer Nanotechnology

Fig. 5

From: Hyaluronated nanoparticles deliver raloxifene to CD44-expressed colon cancer cells and regulate lncRNAs/miRNAs epigenetic cascade

Fig. 5

WI-38 normal cell proliferation. The effect of RX-based free and nano-therapeutic regimens (RX, RX-CS NPs (F1), RX-CS NPs (F2), and RX-HA-CS nanoparticles on WI-38 cells). The cells were treated with these free and nano-regimens using different doses ranging from 0 µM “control” to 100 µM over 24 h (A) and 48 h (B). RX raloxifene, HA hyaluronic acid, CS chitosan, NPs nanoparticles

Back to article page

Cancer Nanotechnology

ISSN: 1868-6966

Contact us